International Biomedical Research Alliance
International Biomedical Research Alliance faces significant deficit in 2023 after fluctuating revenue.
EIN: 203382296 · Washington, DC · NTEE: H99 · Updated: 2026-03-28
| Metric | Value |
|---|---|
| Total Revenue | $293K |
| Total Expenses | $377K |
| Program Spending | 85% |
| Net Assets | $321K |
| Transparency Score | 75/100 |
Is International Biomedical Research Alliance Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
International Biomedical Research Alliance directs 85% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About International Biomedical Research Alliance
International Biomedical Research Alliance (EIN: 203382296) is a nonprofit organization based in Washington, DC, classified under NTEE code H99. The organization reported total revenue of $293K and total assets of $114K according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of International Biomedical Research Alliance's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
International Biomedical Research Alliance is a small nonprofit that has been operating for 21 years, with 13 years of IRS 990 filings on record (2012–2023). Revenue has grown at a compound annual rate of 21.0%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $206K |
| Total Expenses | $377K |
| Surplus / Deficit | $-170,593 |
| Total Assets | $324K |
| Total Liabilities | $3K |
| Net Assets | $321K |
| Operating Margin | -82.7% |
| Debt-to-Asset Ratio | 0.8% |
| Months of Reserves | 10.3 months |
Financial Health Grade: B
In 2023, International Biomedical Research Alliance reported a deficit of $171K with expenses exceeding revenue, holds 10.3 months of operating reserves (strong position), has a debt-to-asset ratio of 0.8% (very low leverage).
Financial Trends
Over 13 years of filings (2012–2023), International Biomedical Research Alliance's revenue has grown at a compound annual growth rate (CAGR) of 21.0%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | -79.6% | -64.0% | -34.7% |
| 2022 | +231.8% | +529.8% | -6.8% |
| 2021 | +6.2% | -19.0% | +35.9% |
| 2020 | +5.4% | -22.2% | +24.7% |
| 2019 | +5.4% | +28.8% | +4.4% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 2005 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates International Biomedical Research Alliance with a Mission Score of 75 out of 100 (Good). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 10%
- programs: 85%
- fundraising: 5%
According to IRS 990 filings, International Biomedical Research Alliance allocates its expenses as follows: admin: 10%, programs: 85%, fundraising: 5%. With 85% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a deficit of $171K, with expenses exceeding revenue.
- Debt-to-asset ratio: 0.8%.
Executive Compensation Analysis
Executive compensation is consistently reported as 0% across all available filings, indicating that no funds are used for officer salaries, which is highly efficient for an organization of its size.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of International Biomedical Research Alliance's IRS 990 filings:
- Significant operating deficit in 2023 ($170,593)
- Inconsistent revenue streams, with large fluctuations year-over-year
- Expenses exceeding revenue in multiple recent periods (2023, 2022, 2016)
Strengths
The following positive indicators were identified for International Biomedical Research Alliance:
- Consistent 0% officer compensation, indicating high efficiency in executive pay
- Long history of public IRS 990 filings (13 years), demonstrating transparency
- Generally low liabilities, indicating good financial management of short-term debt
- Accumulation of assets over time, providing some financial cushion
Frequently Asked Questions about International Biomedical Research Alliance
Is International Biomedical Research Alliance a legitimate charity?
International Biomedical Research Alliance (EIN: 203382296) is a registered tax-exempt nonprofit based in Washington DC. Our AI analysis gives it a Mission Score of 75/100. It has 13 years of IRS 990 filings on record. Total revenue: $293K. 3 red flags identified. 4 strengths noted. Financial health grade: B.
How does International Biomedical Research Alliance spend its money?
International Biomedical Research Alliance directs 85% of its spending to programs and services. Fundraising costs 5%. This exceeds the 65% industry benchmark.
Are donations to International Biomedical Research Alliance tax-deductible?
International Biomedical Research Alliance is registered as a tax-exempt nonprofit (EIN: 203382296). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
What percentage of International Biomedical Research Alliance's spending goes to programs?
International Biomedical Research Alliance directs 85% to programs, 5% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
How does International Biomedical Research Alliance compare to similar nonprofits?
With a transparency score of 75/100 (Good), International Biomedical Research Alliance is above average for NTEE category H99 nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.
Where is International Biomedical Research Alliance located?
International Biomedical Research Alliance is headquartered in Washington, Washington DC and files with the IRS under EIN 203382296. It is classified under NTEE code H99.
How many years of IRS 990 filings does International Biomedical Research Alliance have?
International Biomedical Research Alliance has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $293K in total revenue.
Is International Biomedical Research Alliance a good charity?
The organization demonstrates strong commitment to its mission by not paying officer compensation. However, its financial stability is a concern due to significant deficits in 2023 and 2022, where expenses exceeded revenue by $170,593 and $37,058 respectively. A 'good' charity typically maintains financial stability and consistent program delivery.
What caused the large revenue spike in 2022?
The provided data shows a revenue spike to $1,009,928 in 2022 from $304,361 in 2021. Without access to the full 990 form, the specific source of this increase (e.g., a large grant, specific fundraising event) cannot be determined.
How does the organization manage its liabilities?
Liabilities have generally remained low, ranging from $0 to $4,548 across most years, with the highest reported at $4,186 in 2022 and $2,566 in 2023. This indicates good management of short-term obligations.
What is the trend in the organization's net assets?
Net assets have shown a general upward trend over the years, from $150,053 in 2014 to $324,062 in 2023, despite recent deficits. This indicates a build-up of reserves over the long term, though the 2023 deficit could impact future growth.
Filing History
IRS 990 filing history for International Biomedical Research Alliance showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2012–2023), International Biomedical Research Alliance's revenue has grown by 711.7%, moving from $25K to $206K. Total assets increased by 657% over the same period, from $43K to $324K. Total functional expenses rose by 915.2%, from $37K to $377K. In its most recent filing year (2023), International Biomedical Research Alliance reported a deficit of $171K, with expenses exceeding revenue. The organization holds $3K in liabilities against $324K in assets (debt-to-asset ratio: 0.8%), resulting in net assets of $321K.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $206K | $377K | $324K | $3K | — | — |
| 2022 | $1.0M | $1.0M | $496K | $4K | — | — |
| 2021 | $304K | $166K | $532K | $3K | — | View 990 |
| 2020 | $287K | $205K | $392K | $766 | — | — |
| 2019 | $272K | $264K | $314K | $5K | — | View 990 |
| 2018 | $258K | $205K | $301K | $0 | — | View 990 |
| 2017 | $254K | $186K | $240K | $0 | — | View 990 |
| 2016 | $226K | $234K | $165K | $0 | — | View 990 |
| 2015 | $163K | $146K | $170K | $0 | — | View 990 |
| 2014 | $146K | $47K | $150K | $0 | — | View 990 |
| 2014 | $92K | $103K | $55K | $0 | — | View 990 |
| 2013 | $75K | $52K | $66K | $0 | — | View 990 |
| 2012 | $25K | $37K | $43K | $0 | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $206K, expenses of $377K, and assets of $324K (revenue -79.6% year-over-year).
- 2022: Revenue of $1.0M, expenses of $1.0M, and assets of $496K (revenue +231.8% year-over-year).
- 2021: Revenue of $304K, expenses of $166K, and assets of $532K (revenue +6.2% year-over-year).
- 2020: Revenue of $287K, expenses of $205K, and assets of $392K (revenue +5.4% year-over-year).
- 2019: Revenue of $272K, expenses of $264K, and assets of $314K (revenue +5.4% year-over-year).
- 2018: Revenue of $258K, expenses of $205K, and assets of $301K (revenue +1.4% year-over-year).
- 2017: Revenue of $254K, expenses of $186K, and assets of $240K (revenue +12.3% year-over-year).
- 2016: Revenue of $226K, expenses of $234K, and assets of $165K (revenue +38.7% year-over-year).
- 2015: Revenue of $163K, expenses of $146K, and assets of $170K (revenue +12.2% year-over-year).
- 2014: Revenue of $146K, expenses of $47K, and assets of $150K (revenue +58.5% year-over-year).
- 2014: Revenue of $92K, expenses of $103K, and assets of $55K (revenue +22.4% year-over-year).
- 2013: Revenue of $75K, expenses of $52K, and assets of $66K (revenue +195.3% year-over-year).
- 2012: Revenue of $25K, expenses of $37K, and assets of $43K.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for International Biomedical Research Alliance:
Data Sources and Methodology
This transparency report for International Biomedical Research Alliance is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.